(CGC) Canopy Growth - Ratings and Ratios

Exchange: NASDAQ • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA1380351009

Cannabis, Vaporizers, Edibles, Oils, Joints

CGC EPS (Earnings per Share)

EPS (Earnings per Share) of CGC over the last years for every Quarter: "2020-03": 1.26, "2020-06": -0.3, "2020-09": -0.09, "2020-12": -2.43, "2021-03": -1.85, "2021-06": 0.97, "2021-09": -0.03, "2021-12": -0.29, "2022-03": -1.47, "2022-06": -5.24, "2022-09": -0.49, "2022-12": -5.49, "2023-03": -12.8, "2023-06": -0.69, "2023-09": -4.33, "2023-12": -2.61, "2024-03": -1.03, "2024-06": -1.6, "2024-09": -1.48, "2024-12": -1.1, "2025-03": -2.04,

CGC Revenue

Revenue of CGC over the last years for every Quarter: 2020-03: 107.913, 2020-06: 110.416, 2020-09: 135.266, 2020-12: 152.528, 2021-03: 148.439, 2021-06: 136.209, 2021-09: 131.374, 2021-12: 140.972, 2022-03: 111.77, 2022-06: 110.115, 2022-09: 117.863, 2022-12: 101.213, 2023-03: 87.535, 2023-06: 108.726, 2023-09: 69.595, 2023-12: 78.505, 2024-03: 72.788, 2024-06: 66.167, 2024-09: 62.888, 2024-12: 74.711, 2025-03: 64.657,

Description: CGC Canopy Growth

Canopy Growth Corporation is a leading cannabis and hemp-based products company with a diverse portfolio of brands and products. The company operates through three main segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel. Its product lineup includes dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles, and vaporizer devices, sold under various brands such as Tweed, 7ACRES, DOJA, and Storz & Bickel, among others.

The companys strategic expansion into international markets, particularly in Germany, has positioned it for growth in the global cannabis industry. Canopy Growth has also made significant investments in its production capabilities, allowing it to meet increasing demand for its products. The companys brand portfolio, which includes Martha Stewart and Wana, is well-established and continues to drive sales.

Analyzing the , CGCs current price is $1.31, with its SMA20 and SMA50 at $1.25 and $1.15, respectively, indicating a positive trend. However, the SMA200 at $3.35 suggests a significant long-term downtrend. The ATR of 0.13 represents a 10.30% volatility, which is relatively high. The stock is currently trading near its 52-week low of $0.83, but far from its 52-week high of $11.00.

Considering the , Canopy Growths market capitalization is approximately $272.20M USD, with a negative P/E ratio and a significant negative RoE of -88.02%. This indicates that the company is currently unprofitable, which is not uncommon in the cannabis industry. However, the lack of earnings makes traditional valuation methods challenging.

Forecasting CGCs future performance, a combination of technical and fundamental analysis suggests that the stock may continue to experience volatility. The recent positive trend indicated by SMA20 and SMA50 may continue if the company can demonstrate improved profitability or significant growth in its international markets. However, the long-term downtrend and high volatility must be carefully monitored. A potential target price could be around $2.50, based on a potential retracement to its previous support levels, but this would require a significant improvement in the companys financials and overall market conditions.

Additional Sources for CGC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CGC Stock Overview

Market Cap in USD 261m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC Sub-Industry Pharmaceuticals
IPO / Inception 2014-04-04

CGC Stock Ratings

Growth Rating -92.4
Fundamental -68.8
Dividend Rating 0.0
Rel. Strength -79.4
Analysts 2.5 of 5
Fair Price Momentum 0.42 USD
Fair Price DCF -

CGC Dividends

Currently no dividends paid

CGC Growth Ratios

Growth Correlation 3m 20.3%
Growth Correlation 12m -91.7%
Growth Correlation 5y -95.4%
CAGR 5y -62.90%
CAGR/Max DD 5y -0.63
Sharpe Ratio 12m -1.94
Alpha -95.49
Beta 1.228
Volatility 96.16%
Current Volume 13633.8k
Average Volume 20d 8440.1k
Stop Loss 1.1 (-10.6%)
What is the price of CGC shares?
As of July 09, 2025, the stock is trading at USD 1.23 with a total of 13,633,761 shares traded.
Over the past week, the price has changed by +8.85%, over one month by -24.07%, over three months by +48.51% and over the past year by -80.35%.
Is Canopy Growth a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Canopy Growth (NASDAQ:CGC) is currently (July 2025) a stock to sell. It has a ValueRay Fundamental Rating of -68.77 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CGC is around 0.42 USD . This means that CGC is currently overvalued and has a potential downside of -65.85%.
Is CGC a buy, sell or hold?
Canopy Growth has received a consensus analysts rating of 2.50. Therefor, it is recommend to sell CGC.
  • Strong Buy: 0
  • Buy: 2
  • Hold: 4
  • Sell: 1
  • Strong Sell: 3
What are the forecasts for CGC share price target?
According to our own proprietary Forecast Model, CGC Canopy Growth will be worth about 0.5 in July 2026. The stock is currently trading at 1.23. This means that the stock has a potential downside of -60.16%.
Issuer Target Up/Down from current
Wallstreet Target Price 2.3 87.8%
Analysts Target Price 2.3 85.4%
ValueRay Target Price 0.5 -60.2%